Clinical Trial Update: Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation) [Phase 4]

View source ↗

Summary

A Phase 4, multi-center randomized trial evaluating direct stenting vs pre-dilatation with the CoStar paclitaxel-eluting coronary stent in coronary artery disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CoStar Paclitaxel-Eluting Coronary Stent (paclitaxel-eluting stent)

Snippet

Sponsor: Conor Medsystems | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED